Clinical Trial Update: Docetaxel in Treating Patients With Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

This document provides a Phase 3 clinical trial update on using docetaxel to treat non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Istituto Nazionale per lo Studio e la Cura dei Tumori | Conditions: Lung Cancer | Phase 3 | Status: UNKNOWN